Why Vitamin D Supplements Don't Work for Some People: Genetics

The standard narrative around vitamin D is straightforward: get more sun, take a supplement if you cannot, and aim for a serum 25(OH)D level above 30 ng/mL. For many people, that approach works. But for others, it does not, and the explanation that is most often missed sits at the genetic level.

Before we get to the genetics, it helps to understand the different points in the vitamin D pathway where things can go wrong. Because there are several distinct reasons why supplementation might fall short, and they require different solutions.

The Vitamin D Pathway: Where Problems Can Occur

Vitamin D does not arrive in your cells in a ready-to-use form. It goes through a multi-step conversion process, and each step is a potential bottleneck. Here is the chain:

1. Synthesis or intake: Vitamin D3 is produced in the skin from UVB exposure, or consumed through food and supplements.
2. Liver conversion: D3 is converted to 25-hydroxyvitamin D (25(OH)D, the form measured in blood tests) by the enzyme CYP2R1 in the liver. This requires magnesium.
3. Kidney activation: 25(OH)D is converted to the active form, 1,25-dihydroxyvitamin D3 (calcitriol), by the enzyme CYP27B1 in the kidneys. This also requires magnesium.
4. Receptor binding: Calcitriol binds to the Vitamin D Receptor (VDR) inside target cells.
5. Gene activation: The calcitriol-VDR complex moves to the nucleus and activates vitamin D-responsive genes, producing the downstream biological effects.

A standard blood test measures only step 2 (your circulating 25(OH)D level). It tells you nothing about what happens at steps 4 and 5, which is where genetic variation in the VDR gene becomes critically important.

Non-Genetic Reasons Supplements Fall Short

Before attributing poor vitamin D response to genetics, it is worth ruling out the more common non-genetic causes. Several of these are surprisingly widespread.

Magnesium Deficiency

This is probably the most underappreciated factor in vitamin D biology. Both the liver enzyme that creates 25(OH)D and the kidney enzyme that activates it require magnesium as a cofactor. Studies estimate that up to 50% of Americans consume less magnesium than the recommended daily amount. If you are deficient in magnesium, you cannot efficiently activate vitamin D regardless of how much you supplement. Many people who start taking magnesium alongside their vitamin D supplement notice a rapid improvement in their vitamin D blood levels without changing their vitamin D dose at all.

Poor Supplement Form or Absorption

Vitamin D3 (cholecalciferol) is better absorbed and more potent than vitamin D2 (ergocalciferol). Some cheap supplements still use D2. Additionally, vitamin D is fat-soluble, which means it is significantly better absorbed when taken with a meal that contains some dietary fat. Taking it on an empty stomach or with a fat-free meal reduces absorption substantially.

Obesity and Body Fat Distribution

Vitamin D is stored in adipose tissue. In individuals with higher body fat percentages, a greater proportion of supplemented vitamin D gets sequestered in fat cells rather than entering circulation. This is why research consistently shows that heavier individuals need higher doses to achieve the same serum 25(OH)D levels as leaner individuals.

Gut Absorption Issues

Conditions like celiac disease, Crohn's disease, and other forms of inflammatory bowel disease can impair fat absorption broadly, reducing vitamin D uptake from the gut. Bariatric surgery, particularly procedures that bypass the small intestine, has a similar effect.

When Genetics Is the Primary Explanation

If you have addressed the non-genetic factors above and your vitamin D levels remain low, or your levels are normal but you still experience symptoms strongly associated with vitamin D insufficiency, the explanation may lie in your Vitamin D Receptor (VDR) gene.

The VDR gene encodes the receptor protein that sits inside your cells and translates circulating calcitriol into biological action. Variants in this gene can reduce receptor potency, lower the number of receptor molecules a cell produces, or alter the receptor's ability to bind to DNA and activate downstream genes. When this happens, a person can have a "sufficient" blood level of 25(OH)D and still experience the functional consequences of vitamin D deficiency, because the receptor at the end of the chain is not performing efficiently.

Four specific VDR variants are the most thoroughly studied: FokI (rs10735810), BsmI (rs1544410), ApaI (rs7975232), and TaqI (rs731236). Each affects the receptor through a different mechanism. The FokI variant changes the structure of the receptor protein itself, making it less potent. The other three affect how many receptor molecules are produced and how well they interact with DNA in target tissues.

The Two-Tier Problem: Levels vs. Response

This distinction between vitamin D levels and vitamin D response is central to understanding why supplementation fails for some people. Clinical practice currently focuses almost entirely on serum 25(OH)D, which is a reasonable proxy for most people. But for those with functionally significant VDR variants, it is the wrong endpoint.

Consider two people with identical serum 25(OH)D levels of 45 ng/mL. Person A has two normal-functioning FokI alleles and a favorable haplotype across the other three VDR variants. Their cells are converting that circulating vitamin D into active calcitriol and the receptor is processing it with full efficiency. Person B has the homozygous impaired genotype at FokI and two additional impaired variants. Their calcitriol is present and binding to the receptor, but the receptor is producing only a fraction of the transcriptional output that Person A's receptor achieves.

Both would be told by their doctor that their vitamin D level is fine. Only one of them actually has fine vitamin D function.

What You Can Actually Do About It

A VDR variant is not fixable in the conventional sense, since your genotype is fixed. But its functional impact is highly modifiable. Several targeted strategies can meaningfully improve outcomes for people with impaired VDR function:

Target a Higher Serum 25(OH)D Level

If your receptor is less efficient, you need more of the ligand available to produce the same biological signal. Many researchers who study VDR polymorphisms recommend that individuals with impaired genotypes aim for 25(OH)D levels in the 60-80 ng/mL range rather than the minimum 30 ng/mL threshold, subject to clinician guidance and regular monitoring.

Prioritize Magnesium First

For anyone with a VDR variant, addressing magnesium deficiency is the highest-leverage first step. Magnesium deficiency compounds the receptor problem by limiting even the activation of whatever vitamin D is present. Magnesium glycinate or magnesium malate are well-tolerated forms; magnesium oxide has poor bioavailability and should generally be avoided.

Add Vitamin K2

When the VDR's calcium transport genes are less active, K2 becomes more important for ensuring that calcium absorption is properly directed into bone tissue. The MK-7 form of K2 has the longest half-life in circulation and is the most studied in this context.

Ensure Adequate Zinc

The VDR's DNA-binding domain contains two zinc-finger structures. These structures are essential for the receptor to physically attach to vitamin D response elements on DNA. For a full mechanistic breakdown of this dependency, see our article on magnesium, zinc, and VDR cofactor requirements. Without adequate zinc, even a structurally normal receptor cannot do its job effectively, and for someone whose receptor is already partially impaired, this compounds the deficit.

Know Your Genotype

If you have already done a consumer DNA test (AncestryDNA or 23andMe), you have access to your raw genotype data, which contains all four VDR variants covered here. Analyzing this data takes seconds with the right tool and gives you a specific, actionable picture of your receptor function rather than guessing based on symptoms alone.

The Bigger Picture

Vitamin D biology is more complex than the "take a supplement and check your blood level" model that has dominated clinical practice. For people without VDR variants, that model works reasonably well. For the 20-40% of people who carry at least one impaired VDR genotype, it leaves a significant gap between measured levels and actual biological function.

The fact that this information is now accessible to anyone who has taken a consumer DNA test means that the precision available to researchers for decades can now be applied practically. You do not need to spend years troubleshooting supplementation protocols by trial and error. Your DNA already contains the answer to why your current approach may not be working.